QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors

NCT00563680 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Askin's Tumors
Desmoplastic Small Round Cell Tumors
Estraosseous Ewing's Tumor
Ewing's Family Tumor
Ewing's Sarcoma
Primitive Neuroectodermal Tumors (PNETs)
Sarcoma

Interventions

DRUG: AMG 479

Sponsor

NantCell, Inc.